Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. [electronic resource]
Producer: 20140501Description: 1105-14 p. digitalISSN:- 1873-7862
- Adult
- Aged
- Biomarkers -- metabolism
- Citalopram -- administration & dosage
- Cytokines -- biosynthesis
- Depressive Disorder -- drug therapy
- Drug Delivery Systems -- methods
- Female
- Humans
- Inflammation Mediators -- metabolism
- Male
- Middle Aged
- Pharmacogenetics -- methods
- Polymorphism, Single Nucleotide -- genetics
- Selective Serotonin Reuptake Inhibitors -- administration & dosage
- Transcriptome -- physiology
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- biosynthesis
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.